{"id":137668,"date":"2021-12-21T11:25:05","date_gmt":"2021-12-21T05:55:05","guid":{"rendered":"https:\/\/www.caravanalive.com\/?p=137668"},"modified":"2022-04-06T17:09:20","modified_gmt":"2022-04-06T11:39:20","slug":"bharat-biotech-applied-for-phase-iii-trial-of-booster-dose-of-nasal-vaccine","status":"publish","type":"post","link":"https:\/\/www.caravanalive.com\/?p=137668","title":{"rendered":"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine"},"content":{"rendered":"<div class=\"2a6a8c3593e6620bd92d71f585bdd19b\" data-index=\"4\" style=\"float: none; margin:10px 0 10px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-6453632170035383\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- NEW RESPONSIVE -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-6453632170035383\"\r\n     data-ad-slot=\"2960496911\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n\n<p>The country&#8217;s leading biotechnology company Bharat Biotech has applied to the DGCI (Pharmaceutical Controller General of India) for the Phase III trial of a booster dose of its nasal anti-Covid vaccine. Giving this information on Monday, sources said that this booster dose can be given to those people who have got any of the vaccine either Covaxin or Covishield.<\/p>\n\n\n\n<p>As we all know these days the country is currently at risk of a new and more infectious Omicron variant of the corona virus. Cases of infection have started increasing once again in the country and it is feared that by February next year, the third wave of corona pandemic may come in the country. Day by day the cases of the variant of the corona virus are increasing that too in different states. Even to counter it the international flights are also called off till the new year i.e. January 2022. Some reports suggest that the nasal vaccine may provide protection against the Omicron variant.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/COVOVAX-1024x576.webp\" alt=\"\" class=\"wp-image-137600\" srcset=\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/COVOVAX-1024x576.webp 1024w, https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/COVOVAX-300x169.webp 300w, https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/COVOVAX-768x432.webp 768w, https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/COVOVAX.webp 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">&#8216;Vaccines can be improved for new variants&#8217;<\/h3>\n\n\n\n<p>Dr. Randeep Guleria, the Director of the All Indian Institute of Medical Sciences (AIIMS) Delhi has said that some changes can be made in the existing vaccines to protect against the new variant of the corona virus. His remarks come amid fears of a threat from Omicron. He said that we will have second generation vaccines. This is something we should keep in mind. Existing vaccines are effective but immunity is reduced in case of newer variants.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/1174-1024x576.png\" alt=\"\" class=\"wp-image-137091\" srcset=\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/1174-1024x576.png 1024w, https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/1174-300x169.png 300w, https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/1174-768x432.png 768w, https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/1174.png 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Nasal vaccine may prove to be effective<\/h3>\n\n\n\n<p>According to health experts, many viruses like SARS-CoV-2 normally enter the body through the mucosa. It is a tissue present in the nose. The virus infects cells and molecules present in the mucosal membrane. In such a situation, by giving a dose of vaccine to the person through the nose, a virus can be eliminated before it enters the body.<\/p>\n\n\n\n<p>According to experts, the nasal vaccine produces immunoglobulin A (IgA), which can inhibit the virus by producing a strong immune response in the nose itself, the site of entry of the virus. It helps fight infection and also prevents transmission. Nasal vaccines produce a strong and effective mucosal immune response.<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>The country&#8217;s leading biotechnology company Bharat Biotech has applied to the DGCI (Pharmaceutical Controller General of India) for the Phase III trial of a booster dose of its nasal anti-Covid vaccine. Giving this information on Monday, sources said that this booster dose can be given to those people who have got any of the vaccine [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":137701,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[{"category_id":146,"category_link":"https:\/\/www.caravanalive.com\/?cat=146","category_name":"COVID-19"},{"category_id":143,"category_link":"https:\/\/www.caravanalive.com\/?cat=143","category_name":"Vaccine"}],"tags":[{"tag_id":893,"tag_link":"https:\/\/www.caravanalive.com\/?tag=bharat-biotech","tag_name":"bharat biotech"},{"tag_id":2171,"tag_link":"https:\/\/www.caravanalive.com\/?tag=nasal-vaccine","tag_name":"nasal vaccine"},{"tag_id":895,"tag_link":"https:\/\/www.caravanalive.com\/?tag=vaccine","tag_name":"vaccine"},{"tag_id":2170,"tag_link":"https:\/\/www.caravanalive.com\/?tag=variants","tag_name":"variants"}],"class_list":["post-137668","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus","category-vaccine","tag-bharat-biotech","tag-nasal-vaccine","tag-vaccine","tag-variants"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine - Alive<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.caravanalive.com\/?p=137668\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine - Alive\" \/>\n<meta property=\"og:description\" content=\"The country&#8217;s leading biotechnology company Bharat Biotech has applied to the DGCI (Pharmaceutical Controller General of India) for the Phase III trial of a booster dose of its nasal anti-Covid vaccine. Giving this information on Monday, sources said that this booster dose can be given to those people who have got any of the vaccine [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.caravanalive.com\/?p=137668\" \/>\n<meta property=\"og:site_name\" content=\"Alive\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-21T05:55:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-06T11:39:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gunjan Chaudhary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gunjan Chaudhary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668\"},\"author\":{\"name\":\"Gunjan Chaudhary\",\"@id\":\"https:\/\/caravanalive.com\/#\/schema\/person\/387dd02c14711746a38d502829ef6a39\"},\"headline\":\"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine\",\"datePublished\":\"2021-12-21T05:55:05+00:00\",\"dateModified\":\"2022-04-06T11:39:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668\"},\"wordCount\":380,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/caravanalive.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg\",\"keywords\":[\"bharat biotech\",\"nasal vaccine\",\"vaccine\",\"variants\"],\"articleSection\":[\"COVID-19\",\"Vaccine\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.caravanalive.com\/?p=137668#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668\",\"url\":\"https:\/\/www.caravanalive.com\/?p=137668\",\"name\":\"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine - Alive\",\"isPartOf\":{\"@id\":\"https:\/\/caravanalive.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg\",\"datePublished\":\"2021-12-21T05:55:05+00:00\",\"dateModified\":\"2022-04-06T11:39:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.caravanalive.com\/?p=137668\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668#primaryimage\",\"url\":\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg\",\"contentUrl\":\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.caravanalive.com\/?p=137668#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.caravanalive.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/caravanalive.com\/#website\",\"url\":\"https:\/\/caravanalive.com\/\",\"name\":\"Alive\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/caravanalive.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/caravanalive.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/caravanalive.com\/#organization\",\"name\":\"Alive\",\"url\":\"https:\/\/caravanalive.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/caravanalive.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2024\/01\/alivelogo.png\",\"contentUrl\":\"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2024\/01\/alivelogo.png\",\"width\":220,\"height\":55,\"caption\":\"Alive\"},\"image\":{\"@id\":\"https:\/\/caravanalive.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/caravanalive.com\/#\/schema\/person\/387dd02c14711746a38d502829ef6a39\",\"name\":\"Gunjan Chaudhary\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/caravanalive.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96bc905ebbd529597ee18ff8fa8f738eba19fe3f96acb8950538d44ff4a5ad0e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96bc905ebbd529597ee18ff8fa8f738eba19fe3f96acb8950538d44ff4a5ad0e?s=96&d=mm&r=g\",\"caption\":\"Gunjan Chaudhary\"},\"url\":\"https:\/\/www.caravanalive.com\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine - Alive","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.caravanalive.com\/?p=137668","og_locale":"en_US","og_type":"article","og_title":"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine - Alive","og_description":"The country&#8217;s leading biotechnology company Bharat Biotech has applied to the DGCI (Pharmaceutical Controller General of India) for the Phase III trial of a booster dose of its nasal anti-Covid vaccine. Giving this information on Monday, sources said that this booster dose can be given to those people who have got any of the vaccine [&hellip;]","og_url":"https:\/\/www.caravanalive.com\/?p=137668","og_site_name":"Alive","article_published_time":"2021-12-21T05:55:05+00:00","article_modified_time":"2022-04-06T11:39:20+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg","type":"image\/jpeg"}],"author":"Gunjan Chaudhary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gunjan Chaudhary","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.caravanalive.com\/?p=137668#article","isPartOf":{"@id":"https:\/\/www.caravanalive.com\/?p=137668"},"author":{"name":"Gunjan Chaudhary","@id":"https:\/\/caravanalive.com\/#\/schema\/person\/387dd02c14711746a38d502829ef6a39"},"headline":"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine","datePublished":"2021-12-21T05:55:05+00:00","dateModified":"2022-04-06T11:39:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.caravanalive.com\/?p=137668"},"wordCount":380,"commentCount":0,"publisher":{"@id":"https:\/\/caravanalive.com\/#organization"},"image":{"@id":"https:\/\/www.caravanalive.com\/?p=137668#primaryimage"},"thumbnailUrl":"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg","keywords":["bharat biotech","nasal vaccine","vaccine","variants"],"articleSection":["COVID-19","Vaccine"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.caravanalive.com\/?p=137668#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.caravanalive.com\/?p=137668","url":"https:\/\/www.caravanalive.com\/?p=137668","name":"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine - Alive","isPartOf":{"@id":"https:\/\/caravanalive.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.caravanalive.com\/?p=137668#primaryimage"},"image":{"@id":"https:\/\/www.caravanalive.com\/?p=137668#primaryimage"},"thumbnailUrl":"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg","datePublished":"2021-12-21T05:55:05+00:00","dateModified":"2022-04-06T11:39:20+00:00","breadcrumb":{"@id":"https:\/\/www.caravanalive.com\/?p=137668#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.caravanalive.com\/?p=137668"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.caravanalive.com\/?p=137668#primaryimage","url":"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg","contentUrl":"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2021\/12\/covid-19-vaccine-afp1-e1640066047105.jpg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/www.caravanalive.com\/?p=137668#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.caravanalive.com\/"},{"@type":"ListItem","position":2,"name":"Bharat Biotech Applied for Phase III Trial of Booster Dose of Nasal Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/caravanalive.com\/#website","url":"https:\/\/caravanalive.com\/","name":"Alive","description":"","publisher":{"@id":"https:\/\/caravanalive.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/caravanalive.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/caravanalive.com\/#organization","name":"Alive","url":"https:\/\/caravanalive.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/caravanalive.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2024\/01\/alivelogo.png","contentUrl":"https:\/\/www.caravanalive.com\/wp-content\/uploads\/2024\/01\/alivelogo.png","width":220,"height":55,"caption":"Alive"},"image":{"@id":"https:\/\/caravanalive.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/caravanalive.com\/#\/schema\/person\/387dd02c14711746a38d502829ef6a39","name":"Gunjan Chaudhary","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/caravanalive.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96bc905ebbd529597ee18ff8fa8f738eba19fe3f96acb8950538d44ff4a5ad0e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96bc905ebbd529597ee18ff8fa8f738eba19fe3f96acb8950538d44ff4a5ad0e?s=96&d=mm&r=g","caption":"Gunjan Chaudhary"},"url":"https:\/\/www.caravanalive.com\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=\/wp\/v2\/posts\/137668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=137668"}],"version-history":[{"count":0,"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=\/wp\/v2\/posts\/137668\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=\/wp\/v2\/media\/137701"}],"wp:attachment":[{"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=137668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=137668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caravanalive.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=137668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}